Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Cerebral Infarction; Infarction Phase 3 ClinicalTrials
Cerebral Infarction; Infarction Phase 3 ClinicalTrials
Diabetic Nephropathies; Kidney Diseases Phase 4 ClinicalTrials
CONTENTS